ROVI.MC LABORATORIOS FARMACEUTICOS ROVI | ES0157261019
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 890.792.330 | 771.683.640 | 15.43% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 3,38 | 2,47 | 36.92% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 7 | 4 | 75.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |